0001209191-22-039676.txt : 20220628
0001209191-22-039676.hdr.sgml : 20220628
20220628190744
ACCESSION NUMBER: 0001209191-22-039676
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220516
FILED AS OF DATE: 20220628
DATE AS OF CHANGE: 20220628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bazemore Robert B
CENTRAL INDEX KEY: 0001620152
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 221051389
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvation Bio Inc.
CENTRAL INDEX KEY: 0001811063
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850862255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 754-3517
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: Panacea Acquisition Corp
DATE OF NAME CHANGE: 20200430
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-05-16
2022-05-18
0
0001811063
Nuvation Bio Inc.
NUVB
0001620152
Bazemore Robert B
C/O NUVATION BIO INC.
1500 BROADWAY, SUITE 1401
NEW YORK
NY
10036
1
0
0
0
Stock Option (Right to Buy)
4.05
2022-05-16
4
A
0
140713
0.00
A
2032-05-15
Class A Common Stock
140713
140713
D
100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 16, 2023); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.
This amendment is being filed solely to correct the number of shares covered by the stock option granted on May 16, 2022, which was erroneously reported in the original Form 4 due to an administrative error.
Robert B. Bazemore, Jr., by /s/ Ron A. Metzger, Attorney-in-Fact
2022-06-28